Literature DB >> 19221905

A comparison of two methods of using transtympanic electrocochleography for the diagnosis of Meniere's disease: click summating potential/action potential ratio measurements and tone burst summating potential measurements.

William P R Gibson1.   

Abstract

CONCLUSION: Transtympanic electrocochleography (TT ECochG) is helpful for the confirmation of Meniere's disease using tone burst stimuli to measure the amplitude of the frequency specific summating potentials (SP) but not when using the click evoked summating potential versus action potential ratio (SP/AP).
OBJECTIVES: To evaluate the effectiveness of TT ECochG as a means of confirming the clinical diagnosis of Meniere's disease. PATIENTS AND METHODS: A total of 2,717 patients were referred for TT ECochG between August 1998 and September 2008. Each patient was assessed prospectively on clinical grounds according to the AAOHNS criteria and a scale devised by the author. A Meniere's group and a non-Meniere's group were determined and the TT ECochG results were compared between the groups that had similar hearing levels for the particular stimulus employed.
RESULTS: Click SP/AP measurements did not significantly differentiate between populations of Meniere's ears and non-Meniere's ears. Tone burst SP amplitude measurements were significantly different between the populations, especially using frequencies at 500 Hz, 1 kHz, and 2 kHz.

Entities:  

Mesh:

Year:  2009        PMID: 19221905     DOI: 10.1080/00016480902729843

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  11 in total

1.  Tone burst electrocochleography disproves a diagnosis of Meniere's disease treated aggressively.

Authors:  J Hornibrook; J Gourley; G Vraich
Journal:  HNO       Date:  2020-05       Impact factor: 1.284

2.  Hair cell and neural contributions to the cochlear summating potential.

Authors:  Andrew K Pappa; Kendall A Hutson; William C Scott; J David Wilson; Kevin E Fox; Maheer M Masood; Christopher K Giardina; Stephen H Pulver; Gilberto D Grana; Charles Askew; Douglas C Fitzpatrick
Journal:  J Neurophysiol       Date:  2019-04-03       Impact factor: 2.714

3.  MRI performed after intratympanic gadolinium administration in patients with Ménière's disease: correlation with symptoms and signs.

Authors:  Francesco Fiorino; Francesca B Pizzini; Alberto Beltramello; Franco Barbieri
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-10       Impact factor: 2.503

4.  Transtympanic Electrocochleography for the Diagnosis of Ménière's Disease.

Authors:  Jeremy Hornibrook; Catherine Kalin; Emily Lin; Greg A O'Beirne; John Gourley
Journal:  Int J Otolaryngol       Date:  2012-01-26

5.  MRI Inner Ear Imaging and Tone Burst Electrocochleography in the Diagnosis of Ménière's Disease.

Authors:  Jeremy Hornibrook; Edward Flook; Sam Greig; Melissa Babbage; Tony Goh; Mark Coates; Rachel Care; Philip Bird
Journal:  Otol Neurotol       Date:  2015-07       Impact factor: 2.311

6.  Human Summating Potential Using Continuous Loop Averaging Deconvolution: Response Amplitudes Vary with Tone Burst Repetition Rate and Duration.

Authors:  Alana E Kennedy; Wafaa A Kaf; John A Ferraro; Rafael E Delgado; Jeffery T Lichtenhan
Journal:  Front Neurosci       Date:  2017-07-27       Impact factor: 4.677

Review 7.  The Clinical Uses of Electrocochleography.

Authors:  William P Gibson
Journal:  Front Neurosci       Date:  2017-05-19       Impact factor: 4.677

Review 8.  Ups and Downs in 75 Years of Electrocochleography.

Authors:  Jos J Eggermont
Journal:  Front Syst Neurosci       Date:  2017-01-24

Review 9.  Tone Burst Electrocochleography for the Diagnosis of Clinically Certain Meniere's Disease.

Authors:  Jeremy Hornibrook
Journal:  Front Neurosci       Date:  2017-06-16       Impact factor: 4.677

10.  Normative data for TM electrocochleography measures.

Authors:  Signe Schuster Grasel; Roberto Miquelino de Oliveira Beck; Ricardo Silva Chiabai Loureiro; Amanda Costa Rossi; Edigar Rezende de Almeida; John Ferraro
Journal:  J Otol       Date:  2017-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.